Related Experiment Video
Updated: Aug 30, 2026

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
Published on: July 17, 2019
Anthrax lethal factor-cleavage products of MAPK (mitogen-activated protein kinase) kinases exhibit reduced binding to
A Jane Bardwell1, Mahsa Abdollahi, Lee Bardwell
1Department of Developmental and Cell Biology, 2208 Natural Sciences I, University of California, Irvine, CA 92697, U.S.A.
Abstract:
Anthrax lethal toxin is the major cause of death in systemic anthrax. Lethal toxin consists of two proteins: protective antigen and LF (lethal factor). Protective antigen binds to a cell-surface receptor and transports LF into the cytosol. LF is a metalloprotease that targets MKKs [MAPK (mitogen-activated protein kinase) kinases]/MEKs [MAPK/ERK (extracellular-signal-regulated kinase) kinases], cleaving them to remove a small N-terminal stretch but leaving the bulk of the protein, including the protein kinase domain, intact. LF-mediated cleavage of MEK1 and MKK6 has been shown to inhibit signalling through their cognate MAPK pathways. However, the precise mechanism by which this proteolytic cleavage inhibits signal transmission has been unclear. Here we show that the C-terminal LF-cleavage products of MEK1, MEK2, MKK3, MKK4, MKK6 and MKK7 are impaired in their ability to bind to their MAPK substrates, suggesting a common mechanism for the LF-induced inhibition of signalling.
Insights
Anthrax lethal toxin inhibits cell signaling by targeting MAPK kinases (MKKs/MEKs). The toxin
Area of Science:
- Molecular Biology
- Cellular Signaling
- Toxicology
Background:
- Anthrax lethal toxin (LT) is a primary cause of death in systemic anthrax.
- LT comprises protective antigen (PA) and lethal factor (LF), a metalloprotease.
- LF cleaves MAPK kinases (MKKs/MEKs), inhibiting MAPK signaling pathways.
Purpose of the Study:
- To elucidate the mechanism by which LF-mediated cleavage inhibits MAPK signaling.
- To investigate the effect of LF cleavage on the substrate-binding ability of MKKs/MEKs.
Main Methods:
- In vitro cleavage assays using LF on various MKKs/MEKs.
- Analysis of the substrate-binding capacity of LF-cleaved MKKs/MEKs.
Main Results:
- LF cleaves MEK1, MEK2, MKK3, MKK4, MKK6, and MKK7.
- The C-terminal cleavage products of these kinases exhibit reduced binding to their MAPK substrates.
- This impaired substrate binding suggests a common inhibitory mechanism.
Conclusions:
- LF-induced inhibition of MAPK signaling occurs via impaired substrate binding of cleaved MKKs/MEKs.
- This finding reveals a conserved mechanism for LT-induced cellular dysfunction.
Related Concept Videos
MAPK Signaling Cascades
The Intrinsic Apoptotic Pathway
The JAK-STAT Signaling Pathway
Amplifying Signals via Enzymatic Cascade
The Extrinsic Apoptotic Pathway
Microtubule Associated Proteins (MAPs)

